Records containing: Ulcerative Colitis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2023-11-22Clinical Outcome of Treatment of Ulcerative Colitis in Adult.
-
CLINICAL_TRIALS study record update · 2023-11-13Impact of Osteopathy on IBS-like Symptoms Associated With Ulcerative Colitis in Patients in Remission
-
CLINICAL_TRIALS study record update · 2023-11-09A 54-Week, Multicenter, Randomized, Double-blind, Placebo Controlled, Parallel-group Phase 2 Study to Assess the Efficacy and Safety of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis (Expedition Lead-in)
-
CLINICAL_TRIALS study record update · 2023-11-09A Phase 2 Open-label, Long-term Extension Safety Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis (EXPEDITION OLE)
-
CLINICAL_TRIALS study record update · 2023-11-07Machine Learning Approach and IoT Technologies to Unravel the Complex Interaction Between Environmental Factors and Intestinal Tissue Homeostasis in Chronic Inflammatory Disorders: Sealing the Leaky Gut
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2023-11-03The Mind-Body IBD Study: Understanding the Bidirectional Relationship Between Depression and Anxiety With Physical Health Outcomes and Inflammation
-
CLINICAL_TRIALS study record update · 2023-11-03Development of a Soluble Protein Hydrolysate (SPHi) as a Medical Food for the Treatment of Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2023-11-02The Effect of Therapeutic Fecal Transplant on the Gut Microbiome in Children With Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2023-10-30Microbial and Human Determinants of the Onset of IBD Flares on a National Scale - an Observational Study
-
CLINICAL_TRIALS study record update · 2023-10-27A Multicenter, Open-Label PK Study of Mirikizumab in Pediatric Patients With Moderately to Severely Active Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2023-10-17Phase I, Open-label, Fast-track Dose-escalation Clinical Trial Exploring the Safety and the Tolerability of Autologous ex Vivo Expanded Regulatory T Cells in Adults With Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2023-10-16A Phase 3, Double-Blind, Placebo-Controlled, 40-Week Extension Study to Assess the Efficacy and Safety of Etrasimod in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2023-10-16A Phase I/II, Double Blinded, Placebo Controlled, Single-center Study of Fecal Microbiota Transplant (FMT) for the Treatment of Active Pediatric Ulcerative Colitis and Pediatric Active Crohn's Colitis
-
CLINICAL_TRIALS study record update · 2023-10-10High Dose Interval Vitamin D Supplementation in Patients With IBD Receiving Remicade
-
CLINICAL_TRIALS study record update · 2023-10-05A Personalized Approach to Abdominal Pain in Irritable Bowel Syndrome and Inflammatory Bowel Disease Using Experience Sampling Method (ESM) and a Digital Food Diary (Traqq)
-
CLINICAL_TRIALS study record update · 2023-09-29A Phase II Open-Label Extension Study to Evaluate the Long-Term Safety and Tolerability of UTTR1147A in Patients With Moderate to Severe Ulcerative Colitis or Crohn's Disease
-
CLINICAL_TRIALS study record update · 2023-09-28A Randomized, Placebo Controlled, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of the Subcutaneous Injection of CT-P13 (CT-P13 SC) as Maintenance Therapy in Patients With Moderately to Severely Active Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2023-09-26Adherence of a 1.600 mg Single Tablet 5-ASA Treatment of Ulcerative Colitis (EASI-trial)
-
CLINICAL_TRIALS study record update · 2023-09-22OptiCal Study -Optimizing Fecal Calprotectin Monitoring: a Clinical Study Comparing CalproLab Against PhiCal and Evaluating Its Association With the Gut Microbiome
-
CLINICAL_TRIALS study record update · 2023-09-21Evaluation of the Effectiveness and Cost Effectiveness of an Intervention in Hospitalized Patients With Disease-related Malnutrition
-
CLINICAL_TRIALS study record update · 2023-09-21Vitamin D Regulation of α4β7+ B Cell Immunophenotypes and Mucosal Antibody Response to Commensal Gut Bacteria in Patients With Inflammatory Bowel Disease
-
CLINICAL_TRIALS study record update · 2023-09-11OPTIMIZE-UC: Feasibility of a Multimodal Intervention Program to Optimize Treatment Outcomes in Ulcerative Colitis: A Prospective Pilot Study
-
CLINICAL_TRIALS study record update · 2023-09-07A Randomised, Double-blind, Placebo-controlled Study of Orally Administered BBT-401-1S in Subjects With Moderate to Severe Ulcerative Colitis, Incorporating a Response-adaptive, Double-blind Extension Phase
-
CLINICAL_TRIALS study record update · 2023-09-06A Phase 1b Randomized, Double-blind Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of APL-1401 in Patients With Moderately to Severely Active Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2023-09-06Functional Outcomes of Transanal Ileal Pouch-Anal Anastomosis Compared to Laparoscopic or Open Ileal Pouch-Anal Anastomosis: a Multi-Center, Randomized, Parallel-Group, Non-Inferiority Trial